Company intelligence / Profile preview

Bio-Images Drug Delivery

Glasgow, Scotland, United Kingdompharmaceutical-technology.com ↗

Ownership: Private
Development stage: Commercial

Overview

Bio‑Images Drug Delivery specializes in accelerating early-stage drug development by integrating formulation design, GMP manufacturing, and lean clinical testing. Their proprietary OralogiK™ technology enables precise control over the timing/location of oral drug release. The company’s unique use of gamma scintigraphic imaging allows real-time visualization of how drugs are released/distributed within the body during clinical trials. They provide end-to-end services from concept to early human data, supporting both large pharma and small biotech clients.

Modalities: Small moleculeBiologics
Industry: Contract Research Organization

Partnerships

Works with major global pharmaceutical companies as clients

Beyond the preview

Go deeper on Bio-Images Drug Delivery.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bio-Images Drug Delivery.

Explore the full profile